Mankind Pharma Profit & Loss Annual

Trade
BSE: 543904 | NSE: MANKIND | ISIN: INE634S01028 | Sector: -
2,129.00 -9.90 (-0.46%)Updated : 19 Jul 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 10,334.778,749.437,781.566,214.43
Total Revenue 10,334.778,749.437,781.566,214.43
Costof Revenue Total 3,209.703,071.292,573.141,907.51
Gross Profit 7,125.085,678.155,208.424,306.93
Selling/ General/ Admin Expenses Total 2,274.733,763.953,209.562,583.60
Depreciation/ Amortization 398.25325.86166.56118.92
Other Operating Expenses Total 2,315.28--50.58
Total Operating Expense 8,197.967,174.725,929.564,682.26
Operating Income 2,136.821,574.721,851.991,532.18
Interest Inc( Exp) Net- Non- Op Total -183.18365.311,074.43979.09
Other Net 280.8649.6812.0560.52
Net Income Before Taxes 2,399.361,671.241,974.601,691.61
Provisionfor Income Taxes 457.59361.56521.64398.58
Net Income After Taxes 1,941.771,309.681,452.961,293.03
Minority Interest -28.88-27.82-19.48-27.61
Net Income Before Extra Items 1,912.901,281.861,433.481,265.43
Net Income 1,912.901,281.861,433.481,265.43
Income Availableto Com Excl Extra Ord 1,912.901,281.861,433.481,265.43
Income Availableto Com Incl Extra Ord 1,912.901,281.861,433.481,265.43
Diluted Net Income 1,912.901,281.861,433.481,265.43
Diluted Weighted Average Shares 40.1240.0640.0640.06
Diluted EPS Excluding Extra Ord Items 47.6832.0035.7831.59
Diluted Normalized EPS 47.6832.0635.3631.98
Interest Exp( Inc) Net- Operating Total -0.550.530.55
Unusual Expense( Income) -13.56-19.7521.60
Gain( Loss)on Saleof Assets -103.1431.1510.06
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,792.85+33.70(1.92%)
474.30+4.20(0.89%)
2,945.95+15.50(0.53%)
157.75-8.60 (-5.17%)
364.50-13.25 (-3.51%)
HomeMarketsPremiumInstant LoanBudget